Fatigue before, during and after antiviral therapy of chronic hepatitis C: results from the Virahep-C study | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Fatigue before, during and after antiviral therapy of chronic hepatitis C: results from the Virahep-C study

Sarkar S, Jiang Z, Evon DM, Wahed AS, Hoofnagle JH. Fatigue before, during and after antiviral therapy of chronic hepatitis C: results from the Virahep-C study. J Hepatol. 2012;57(5):946-952.

Publication Type:

Journal Article

Authors:

Sarkar, S.; Jiang, Z.; Evon, D.M.; Wahed, A.S.; Hoofnagle, J.H.

Source:

J Hepatol, Volume 57, Issue 5, p.946-952 (2012)

Keywords:

Adult, Antiviral Agents, Comparative Study, Disease, Dose-Response Relationship,Drug, drug therapy, Drug Therapy,Combination, epidemiology, Fatigue, Female, Fibrosis, genetics, Genotype, genotype 1, HCV, Health, Hepacivirus, hepatitis, Hepatitis C, hepatitis C virus, Hepatitis C,Chronic, Humans, Infection, Interferon-alpha, Kidney, Kidney Diseases, Kinetics, Liver, Longitudinal Studies, Male, Men, methods, Patients, peginterferon, Polyethylene Glycols, Prevalence, Proteins, Recombinant Proteins, Research, Research Support, Retrospective Studies, Ribavirin, Severity of Illness Index, SVR, therapeutic use, therapy, treatment, United States, Women

Notes:

PMC3477271

Cited On:

When and in Whom to Initiate HCV Therapy

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/22760009

Export Citation:

RIS Format

Top